Crossmark

2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives

Crossref DOI link: https://doi.org/10.1007/s11224-022-01913-3

Published Online: 2022-03-15

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Er-rajy, Mohammed https://orcid.org/0000-0001-5460-684X
El Fadili, Mohamed

Hadni, Hanine

Mrabti, Nidal Naceiri

Zarougui, Sara

Elhallaoui, Menana
License Information

Text and Data Mining valid from 2022-03-15

Version of Record valid from 2022-03-15
More Information

Article History

Received: 23 December 2021

Accepted: 3 March 2022

First Online: 15 March 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below